Skip to main content

SAMD3 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85686

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-85686-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of Human SAMD3. Peptide sequence: ALVAAFHVFRIECPRRLSQTFNFLETLIFDMHSPYFPSLKEKENEVGFQH The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for SAMD3 Antibody

Western Blot: SAMD3 Antibody [NBP2-85686]

Western Blot: SAMD3 Antibody [NBP2-85686]

Western Blot: SAMD3 Antibody [NBP2-85686] - WB Suggested Anti-SAMD3 Antibody. Titration: 1.0 ug/ml. Positive Control: Hela Whole Cell

Applications for SAMD3 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: SAMD3

Alternate Names

bA73O6.2, FLJ34032, FLJ34563, MGC35163, SAM domain-containing protein 3, sterile alpha motif domain containing 3, sterile alpha motif domain-containing protein 3

Gene Symbol

SAMD3

Additional SAMD3 Products

Product Documents for SAMD3 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SAMD3 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...